Pharmaceutical Non-Active Ingredients TRIZ Cases

Palladium catalysis produces defect-free water-soluble polyphenyleneethynylene polymers in neat water without inert atmospheres.

Atomizing lactose onto cellulose derivatives creates granules that resolve flow versus strength trade-offs in direct compression.

A peptide composition binds annexin 1 receptors on tumor vasculature to enable selective drug delivery.

Emulsion crosslinking entraps bioactive proteins in a polymer network to prevent denaturation while maintaining enzymatic activity at elevated temperatures.

An organic-aqueous solvent mixture enhances phosphodiesterase inhibitor permeation across mucosal membranes.

High ester pectin capsules replace gelatin and carrageenan, providing puncture strength and immediate drug release without animal-derived materials.

Complexing phytochemicals with proteins, peptides, or polysaccharides via non-covalent conjugation to form stable nutraceutical compositions.

Segmented linkers boost therapeutic activity while hydrophilic spacers maintain water solubility.

Replacing alum or MPL adjuvants with phosphorylated hexaacyl disaccharide derivatives reduces injection site reactions while maintaining immune response.

Masking hydrophobic backbones in organic scaffold particles reduces bitter aftertaste and improves temporal taste profiles for natural non-nutritive sweeteners.

Enzymatic activation of peptide-steroid conjugates triggers self-assembly into nanofibers that interact with cancer cell membranes.

A toroidal mixed nanoparticle with elastic deformation enables effective penetration into blood vessels and tumor lesions.

N3S1 chelator-folate derivatives bind radioisotopes to target alpha-folate receptors, enabling precise imaging and treatment of alpha-FR-positive tumors.

Segmenting the process with a surrogate solution in the first lane eliminates active material waste during parameter adjustment.

A pH-dependent copolymer system reverses charge to release viruses in acidic environments.

An oily excipient binds low-dose drugs to a water-soluble carrier, achieving content uniformity without energy-intensive drying steps.

Novel carboxymethylcellulose polymers establish hydrophilic conditions to enhance drug bioavailability.

Amphiphilic copolymer coatings embed sparingly soluble active ingredients into pellets via spray deposition.

A polydiacetylene liposome encapsulates drugs within a stable lipid bilayer composed of PCDA, DOPE, and PHC.

Cellulose ether base and sweetener blend mask scopolamine butylbromide bitterness in oral sheets.

A transdermal composition employs a donepezil-magnesium chloride eutectic mixture to overcome poor skin permeation and maintain therapeutic efficacy.

Combining directly compressible and non-directly compressible sugar alcohol particles creates discrete areas that induce taste masking during mastication.

Polymer coatings mask viral vectors from neutralizing antibodies and reduce liver uptake, improving circulation time and tumor targeting efficacy.

Hydrolytically degradable fibers maintain stable pH and ensure continuous drug delivery in enzyme-poor environments.

Polyacrylate reservoir delivers rivastigmine without antioxidants, preventing allergic dermatitis while maintaining chemical stability.

Segmenting the drug into a targeting moiety and payload reduces systemic toxicity while maintaining anti-tumor efficacy through controlled activation.

An adhesive patch uses ion-pair formation to lower drug melting point, overcoming horny layer barriers for risperidone permeation.

Polyoxazoline polymer combinations manage sustained release of active ingredients, preventing burst release at high drug loadings.

A disulfide-linked polyethyleneglycol peptide carrier packages immunostimulatory nucleic acids and antigens for simultaneous cellular delivery.

Merging antibodies with benzazepine intermediaries resolves the contradiction between treatment versatility and tumor accessibility.

A phenolic polymerization inhibitor stabilizes polyethylene glycol maleimide derivatives against spontaneous gelation during storage.

Replacing hydrogen with deuterium in polymer chains allows non-invasive MRI detection of disease biomarkers without systemic toxicity.

Glycerol alkyl esters provide therapeutic effects on external wounds despite lacking established prior knowledge of their specific healing capabilities.

A plant-derived capsule shell composition combines starch with locust bean gum to form a durable film.

Co-mixing aluminum salt and phosphate solutions at a defined molar ratio using a buffer to maintain constant pH during precipitation.

Covalent bonding between dispersed droplets creates a cohesive network that maintains shape and resists dilution in aqueous environments.

A pH-responsive polymer transitions from neutral to cationic charge states to accumulate drugs in tumor tissue.

KI-P3F-032 degrades undruggable PAX3-FOXO1 fusion proteins through proximity-inducing ubiquitination, addressing chemotherapy resistance in rhabdomyosarcoma.

Cleavable peptide linkers separate masking motifs from lytic domains upon stimulus exposure to trigger rapid drug release at target sites.

Segmented macrocyclic derivatives balance hydrophilic and lipophilic regions to form stable assemblies that encapsulate diverse compounds.

Cleavable peptide probes activate fluorescence upon protease binding, resolving stability and sensitivity trade-offs in molecular imaging.

Orodispersible films feature inhomogeneous porosity with a closed lower surface and porous upper face to absorb active ingredients.

An aniline catalyst drives oxime bond formation at pH 4.0 to 6.0, achieving high homogeneity and eliminating structural defects in decorated dendrimers.

Water-soluble olive leaf powder films dissolve instantly to deliver concentrated antioxidants in beverages.

Extracellular vesiculation packages therapeutic agents into microbial vesicles, improving bioavailability and reducing side effects.

Water-soluble polymer reagents target histidine residues to enable site-specific protein modification.

L-rhamnose antigen-lipid conjugates replace alpha-Gal lipids to overcome weak cell killing efficacy under physiologically relevant conditions.

Dry granules with tartaric acid stabilize temozolomide against moisture degradation while ensuring uniform capsule content.

Cytocompatible photoinitiators enable rapid gelation of hydrogels without cytotoxic co-monomers, resolving biosafety concerns in biomedical delivery systems.

Crosslinkable copolymer shells encapsulate hydrophobic essential oils to form stable nanocapsule dispersions.